Brief: Hemcheck Sweden Signs Letter Of Intent To Acquire Additional Ip Rights

Bio Vitos Pharma AB

26/09/2023 14:08

Sept 26 (Reuters) - Hemcheck Sweden AB  HEMC.ST :
    * SIGNS LETTER OF INTENT TO ACQUIRE ADDITIONAL IP RIGHTS
    * IF A FINAL TRANSFER AGREEMENT IS SIGNED, CO WILL NOT PAY
ANY
SPECIAL REMUNERATION IN ADDITION TO FUTURE ROYALTIES ON SALES IN
THE NORDIC MARKETS
    * HAS SIGNED A LETTER OF INTENT WITH BIO VITOS AND DOUBLE
BOND
PHARMACEUTICAL
    * LOI  TO ACQUIRE THE IP RIGHTS REGARDING THE USE OF IRON
SUCCINATE FOR THE TREATMENT OF PATIENTS DIAGNOSED WITH HEART
FAILURE WITH REDUCED EJECTION FRACTION (HFREF) IN THE NORDIC
REGION

Source text for Eikon:  ID:nWkr7Nm3cd 
Further company coverage:  HEMC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))